| 000 | 02753 a2200745 4500 | ||
|---|---|---|---|
| 005 | 20250515120547.0 | ||
| 264 | 0 | _c20081002 | |
| 008 | 200810s 0 0 eng d | ||
| 022 | _a0007-1188 | ||
| 024 | 7 |
_a10.1038/bjp.2008.172 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCosta, R | |
| 245 | 0 | 0 |
_aEvidence for the role of neurogenic inflammation components in trypsin-elicited scratching behaviour in mice. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cJul 2008 |
||
| 300 |
_a1094-103 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnilides _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntipruritics _xpharmacology |
| 650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
| 650 | 0 | 4 | _aBradykinin Receptor Antagonists |
| 650 | 0 | 4 |
_aCalcitonin Gene-Related Peptide _xpharmacology |
| 650 | 0 | 4 | _aCalcitonin Gene-Related Peptide Receptor Antagonists |
| 650 | 0 | 4 | _aCelecoxib |
| 650 | 0 | 4 |
_aCell Degranulation _xdrug effects |
| 650 | 0 | 4 |
_aCinnamates _xpharmacology |
| 650 | 0 | 4 |
_aCromolyn Sodium _xpharmacology |
| 650 | 0 | 4 |
_aCyclooxygenase 2 _xmetabolism |
| 650 | 0 | 4 |
_aCyclooxygenase 2 Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aDioxoles _xpharmacology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aInjections, Intradermal |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMast Cells _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aNerve Fibers, Unmyelinated _xmetabolism |
| 650 | 0 | 4 |
_aNeurogenic Inflammation _xchemically induced |
| 650 | 0 | 4 |
_aOligopeptides _xpharmacology |
| 650 | 0 | 4 |
_aPeptide Fragments _xpharmacology |
| 650 | 0 | 4 |
_aPlant Proteins _xpharmacology |
| 650 | 0 | 4 |
_aPruritus _xchemically induced |
| 650 | 0 | 4 |
_aPyrazoles _xpharmacology |
| 650 | 0 | 4 |
_aQuinolines _xpharmacology |
| 650 | 0 | 4 |
_aReceptor, PAR-2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptors, Bradykinin _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Calcitonin Gene-Related Peptide _xmetabolism |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 650 | 0 | 4 |
_aTRPV Cation Channels _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTrypsin _xadministration & dosage |
| 650 | 0 | 4 |
_ap-Methoxy-N-methylphenethylamine _xpharmacology |
| 700 | 1 | _aMarotta, D M | |
| 700 | 1 | _aManjavachi, M N | |
| 700 | 1 | _aFernandes, E S | |
| 700 | 1 | _aLima-Garcia, J F | |
| 700 | 1 | _aPaszcuk, A F | |
| 700 | 1 | _aQuintão, N L M | |
| 700 | 1 | _aJuliano, L | |
| 700 | 1 | _aBrain, S D | |
| 700 | 1 | _aCalixto, J B | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 154 _gno. 5 _gp. 1094-103 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/bjp.2008.172 _zAvailable from publisher's website |
| 999 |
_c17950114 _d17950114 |
||